Though accumulation of FoxP3+ Tregs in majority of human carcinomas is associated with tumor growth and poor outcome, some studies in CRC have shown the presence of Tregs in tumors is associated with better outcome (27), suggesting that in CRC Treg functions might be antitumorigenic by suppressing inflammation at the early stages of the disease. This evidence concerns the gene FOXP3 and neoplasm.